Firms
Theme

WBD

Warner Bros. Discovery, Inc. Series A · NASDAQ

No recent trades · As of 10/5/26

News

7 latest

Zacks Investment Research

Warner Bros. Discovery, Inc. (WBD) is Attracting Investor Attention: Here is What You Should Know

Warner Bros. Discovery (WBD) has outperformed the broader market with a +9.5% return over the past month, despite its industry declining 10.6%. The company holds a Zacks Rank #3 (Hold) rating based on mixed earnings estimate revisions and a D valuation grade, suggesting it may perform in line with the broader market in the near term. Recent results showed revenue decline of 11.2% year-over-year, though EPS surprised positively.

GlobeNewswire Inc.

Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026

Nasdaq announced that Moderna, Inc. (MRNA) will replace Warner Bros. Discovery, Inc. (WBD) as a component of the Nasdaq-100 Index effective October 9, 2026. The Nasdaq-100 Index tracks 100 of the largest Nasdaq-listed non-financial companies and is tracked by over 200 investment products with $800 billion in assets under management globally.

Mentions WBD

The Motley Fool

Paramount and Warner Bros. Discovery to Merge Into Skydance (SKYD). Will Skydance Achieve David Ellison’s “Quality Storytelling” Vision?

Paramount Skydance and Warner Bros. Discovery have completed their merger to form Skydance, set to close on October 6, 2026. However, the new company faces significant headwinds including an $80 billion debt burden, industry opposition from creators, settlement-imposed constraints on film production and studio operations, and a poor historical track record for large media mergers.

The Motley Fool

If I Had $10,000 to Invest Today, Here's the Growth Stock I'd Buy Instead of SpaceX

SpaceX has lost 34% from its peak since going public in June and trades at an expensive P/S ratio of 87, suggesting further downside. Netflix, with a P/S ratio of 6.2 and P/E of 22.4, offers better value and growth potential, having captured only 7% of its $670 billion addressable market. The streaming giant's advertising business is expected to double to $3 billion by 2026, positioning it as a more attractive long-term investment.

The Motley Fool

Most Investors Are Wrong About Selling Netflix. Here's What I'd Do Instead.

Despite Netflix shares falling 25% this year amid concerns about weak engagement and increased competition, analyst Jeremy Bowman argues selling is a mistake. The company maintains strong fundamentals with 13.4% revenue growth, a 33.4% operating margin, and over 300 million subscribers. While per-subscriber engagement may be declining, Netflix's recurring revenue model and potential for live sports content could reignite growth, making the stock a buy at current valuations.

The Motley Fool

Will Netflix Stock Trade for $135 or $70 by September 2027? Here's the Most Likely Scenario.

Netflix stock is down 24% in 2026 and faces uncertain prospects. Analyst price targets for September 2027 range from $70 to $135, with a median of $93.50.

GlobeNewswire Inc.

Reuters Momentum AI Austin Day 1: A New Way to Measure Whether AI Is Actually Paying Off

Enterprise AI is shifting from experimentation to demonstrating measurable ROI. Companies like FedEx ($3B in cost reductions), Mars (20% top-line growth), and Indeed (70% of matches from AI) are scaling AI beyond pilots, but success requires organizational redesign, clear ownership, and human oversight. Leaders warn that AI can amplify existing organizational weaknesses and autonomous agents need defined spending limits and accountability measures.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $WBD · 0 threads

Sign in to post on $WBD

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev